Alleviating Geriatric Inpatients' Medication-related Iatrogenesis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-15

Study Completion Date

2023-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will evaluate the MedWise Risk Score™ (MWRS™), a holistic approach to quantifying the risk of a patient's medication regimen. High risk patients will be identified at hospital discharge. Targeted interventions will be made to reduce their MWRS™ with a 30-day follow up. The hypothesis being tested is that a reduction in MWRS™ will lead to reduced 30-day readmission.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Medication Reviews Performed in High Risk Patients

NCT01819974

Patients in Highest Medication Error Risk

UNKNOWN NA

Improving Safety After Hospitalization in Older Persons on High-Risk Medications

NCT02781662

Medication Safety

COMPLETED NA

The Geriatric Emergency Department Pharmacologic Harm Prevention Project

NCT07216846

Fall Fall Accident Poly Pharmacy +3 more

RECRUITING NA

Reducing Transition Drug Risk

NCT00370916

Hospitalization

COMPLETED NA

Medication Reconciliation in Comparison to an Extensive Medication Safety Check

NCT02413957

Elderly Adverse Drug Event

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Iatrogenic Disease Risk Reduction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Discharge medication regimen instructions will be provided upon discharge after being assessed using the MWRS, optimized, and assessed by the prescriber.

Group Type EXPERIMENTAL

Risk score based intervention

Intervention Type OTHER

Targeted interventions based off of risk score software

Standard of Care

Discharge medication regimen instructions will be provided upon discharge after being assessed by the prescriber.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Risk score based intervention

Targeted interventions based off of risk score software

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hospital admission for at least 48 hours
* Prescribed at least 5 medications at hospital discharge
* Baseline medication risk score of 20 or more

Exclusion Criteria

* Reside greater than 25 miles from the index facility
* Discharge to hospice
* Discharge against medical advice
* Patient expiration during initial hospitalization

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No